Template:ST elevation myocardial infarction: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
'''ST elevation myocardial infarction Microchapters | '''ST elevation myocardial infarction Microchapters''' | ||
''' | |||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
Line 176: | Line 175: | ||
! | ! | ||
[[ST elevation myocardial infarction initial care|Initial Care]] | [[ST elevation myocardial infarction initial care|Initial Care]] | ||
:Oxygen | |||
:Nitrates | |||
:Analgesics | |||
:Aspirin | |||
:Beta Blockers | |||
:Antithrombins | |||
:The coronary care unit | |||
:The step down unit | |||
:STEMI and Out-of-Hospital Cardiac Arrest | |||
:Pharmacologic Reperfusion | |||
::Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) | |||
::Fibrinolysis | |||
:Mechanical Reperfusion | |||
::The importance of reducing Door-to-Balloon times | |||
::Primary PCI | |||
::Adjunctive and Rescue PCI | |||
::Rescue PCI | |||
::Facilitated PCI | |||
::Adjunctive PCI | |||
::CABG | |||
::Management of Patients Who Were Not Reperfused | |||
::Assessing Success of Reperfusion | |||
:Antithrombin Therapy | |||
::Antithrombin therapy | |||
::Unfractionated heparin | |||
::Low Molecular Weight Heparinoid Therapy | |||
::Direct Thrombin Inhibitor Therapy | |||
::Factor Xa Inhibition | |||
::DVT prophylaxis | |||
::Long term anticoagulation | |||
:Antiplatelet Agents | |||
::Aspirin | |||
::Thienopyridine Therapy | |||
::Glycoprotein IIbIIIa Inhibition | |||
:Other Initial Therapy | |||
::Inhibition of the Renin-Angiotensin-Aldosterone System | |||
::Magnesium Therapy | |||
::Glucose Control | |||
::Calcium Channel Blocker Therapy | |||
::Lipid Management | |||
|- | |- | ||
! | ! | ||
Line 188: | Line 227: | ||
! | ! | ||
[[ST elevation myocardial infarction secondary prevention|Long-Term Medical Therapy and Secondary Prevention]] | [[ST elevation myocardial infarction secondary prevention|Long-Term Medical Therapy and Secondary Prevention]] | ||
|- | :Overview | ||
:Inhibition of the Renin-Angiotensin-Aldosterone System | |||
:Cardiac Rehabilitation | |||
:Pacemaker Implantation | |||
:Long Term Anticoagulation | |||
|- | |||
! | |||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! |
Revision as of 18:09, 8 May 2014
ST elevation myocardial infarction Microchapters |
Differentiating ST elevation myocardial infarction from other Diseases |
---|
Diagnosis |
Treatment |
|
Long-Term Medical Therapy and Secondary Prevention
|
Case Studies |
ST elevation myocardial infarction On the Web |
Directions to Hospitals Treating ST elevation myocardial infarction |
Risk calculators and risk factors for ST elevation myocardial infarction |